| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Chesapeake IRB and its Canadian affiliate, IRB Services, have been in business since 1993. They have established a reputation for excellence that is based on quality work, efficient processes, and excellent customer service. Chesapeake IRB`s schedule of 5 weekly meetings, daily expedited review capability, 4 day turnaround for protocols and 24-hour turnaround for Principal Investigators (PIs) has helped our clients become more competitive for industry sponsored studies; including Phase I research. While the majority of our studies are biomedical or device related, we have a broad range of social/behavioral studies that are often government or foundation funded. We work with you as a risk mitigation partner to meet your needs.
Healthtrax, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Center For Growth & Healing is a Kenmore, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amare Global creates a holistic mental wellness platform that connects a purpose-driven community of passionate people. Our vision is to lead the mental wellness revolution. Founder and CEO of Amare Global, Hiep Tran, began his entrepreneurial journey at 23 when he decided that medical school was not for him. He started working for a payments processing company. “For the next 5 years, I surrounded myself with the most successful people I knew, in order to grow and learn from them. Eventually that payments company I was working for was sold. I reached an important crossroads: stay comfortable in my current position or build something for myself. In 2008, together with a partner, we invested all of our savings and co-founded a new company: Meritus Payment Solutions. We started from humble beginnings with five employees in 2008 and surged to over 100 employees by 2014 when we were acquired by Optimal Payments. During those 6 years, I fell in love with helping people achieve their own life-changing success. However, work always came first, family second, and personal health a distant third. I took my health for granted until the consequences became real. Thankfully, I pulled through instead of succumbing to these challenges. I channeled the experience positively, to change my life and learn as much as I could about health and nutrition. The result was a newfound passion.” Thus, Amare Global was created. We focus on the excellence and integrity throughout our product development, people development, and the customer experience. Ultimately, we strive to create products that will inspire people to become better versions of themselves. Amare means "To Love" in Latin and we believe in promoting Love for one`s self, as well as a powerful connection with others. By empowering people to connect through our innovative products and platform, we will grow together and reach beyond our limits.